COLACARDIO ACS Study – Investigators Meeting

The Investigators’ Meeting for the COLCARDIO ACS Study was successfully held on 12th September 2025.
The meeting was led by Prof Sanjay Patel (University of Sydney) along with Rebecca Mister (Clinical Trial Project Manager), bringing together all participating site teams and Principal Investigators in Sri Lanka.

This multicenter randomized trial will investigate whether adding low-dose colchicine to standard post-ACS treatment can reduce recurrent cardiac events in high-risk patients. By targeting atherosclerosis-associated inflammation, the study aims to improve long-term outcomes for heart attack survivors.

This trial is conducted across 10 centres in Sri Lanka, in collaboration with the NHMRC Clinical Trials Centre, University of Sydney.